- Patent Title: Epicardial-derived paracrine factors for repairing cardiac tissue
-
Application No.: US15565054Application Date: 2016-04-08
-
Publication No.: US10682416B2Publication Date: 2020-06-16
- Inventor: Pilar Ruiz-Lozano , Mark Mercola , Ke Wei
- Applicant: Regencor, Inc. , Sanford Burnham Prebys Medical Discovery Institute , EPIKABIO, INC.
- Applicant Address: US CA Los Altos US CA La Jolla
- Assignee: Regencor, Inc.,Sanford Burnham Prebys Medical Discovery Institute
- Current Assignee: Regencor, Inc.,Sanford Burnham Prebys Medical Discovery Institute
- Current Assignee Address: US CA Los Altos US CA La Jolla
- Agency: Mintz Levin Cohn Ferris Glovsky and Popeo PC
- International Application: PCT/US2016/026809 WO 20160408
- International Announcement: WO2016/164840 WO 20161013
- Main IPC: A61K38/00
- IPC: A61K38/00 ; A61K38/16 ; C07K1/00 ; A61K47/42 ; A61K35/34 ; A61K9/00 ; A61K9/70 ; A61K38/17 ; A61K31/7072 ; A61P9/10 ; A61K38/18
Abstract:
Provided herein, inter alia, are compositions and kits comprising epicardial-derived paracrine factors (such as, hypoglycosylated follistatin-like 1 (FSTL1)) for treating and repairing damage to cardiac tissue caused by cardiovascular disease, myocardial infarction (MI), other ischemic events, or cardiac-growth deficiency, as well as methods for using the same.
Public/Granted literature
- US20180092980A1 EPICARDIAL-DERIVED PARACRINE FACTORS FOR REPAIRING CARDIAC TISSUE Public/Granted day:2018-04-05
Information query
IPC分类:
